What is the initial dose of Dantrolene Sodium for treating malignant hyperthermia?

The initial dose of Dantrolene Sodium for treating malignant hyperthermia is 2.5 mg/kg. This medication acts as a muscle relaxant and is specifically used to manage the severe muscle contractions and metabolic crisis associated with malignant hyperthermia, a potentially life-threatening condition triggered by certain anesthetics and succinylcholine.

Administering Dantrolene at this dosage helps to rapidly restore normal calcium levels in the muscle cells and mitigate the hypermetabolic state. Quick and effective management is crucial in these scenarios to reduce the risk of complications and improve patient outcomes. Several guidelines recommend starting with this dosage to ensure adequate therapeutic effect while monitoring for any side effects or the need for additional doses.